Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of JTT-654 on diabetes as well as the
safety, tolerability and pharmacokinetics of JTT-654 in type 2 diabetic patients.